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Introduction: The level of dopamine in the prefrontal cortex (PFC) appears to play a fundamental role in
cognitive alterations in schizophrenia. The Val158Met polymorphism of the catechol-O-methyltransferase
(COMT) enzyme impacts dopamine availability in the prefrontal cortex and can thus influence cognitive
functioning. Among the different cognitive deficits found in schizophrenia patients, context processing
deficits have been noted as a specific characteristic of schizophrenia, for which the cerebral substrate appears
to be located in the dorsolateral PFC. In this study, we examine the impact of the Val158Met COMT
polymorphism on context processing in a sample of patients on the schizophrenia spectrum, their relatives,
and healthy control subjects evaluated using the Dot Probe Expectancy Task (DPX).
Methods: Forty patients on the schizophrenia spectrum, 26 relatives, and 63 healthy control subjects were
genotyped and performed the DPX test. Results: Both patients and their relatives demonstrated deficits in
context processing influenced by the Val158Met COMT polymorphism. Compared with the other subjects, the
Val/Val subjects showed poorer performance on context processing tasks.
Conclusions: Deficits in context processing in schizophrenic patients and their families are influenced by the
Val158Met COMT functional polymorphism, likely as a consequence of reduced dopamine availability in the PFC.
© 2015 Published by Elsevier Inc.1. Introduction
Cognitive deficits are a primary characteristic of schizophrenia that
significantly impact patient functioning (Bowie et al., 2006; Green
et al., 2000). Among other hypotheses, it has been postulated that the
primary cognitive alterations in schizophrenia (working memory and
executive functions) are due to dysfunction in the frontal lobe,
specifically hypodopaminergia in the prefrontal cortex (PFC). Dopa-
minergic tone in the PFC is essential for cognitive functioning. The
catechol-O-methyltransferase (COMT) enzyme is vital for the regu-
lation of dopamine levels in the PFC (review: Tunbridge et al., 2006). A
functional polymorphism of the COMT gene (rs4680) significantly
impacts the dopamine levels in the PFC. The Val allele is associated
with greater enzymatic activity and, therefore, with greater dopamine
degradation in the synapses of the PFC (Chen et al., 2004; Lachman
et al., 1996). This genetic polymorphism, although weakly linked to
the risk of a schizophrenia diagnosis (Glatt et al., 2003), is a good
candidate for understanding the relationships between dopamine
levels in the PFC and cognitive functioning.og.2015.05.004.Many studies have investigated the link between cognition and the
Val158Met COMT polymorphism in both healthy controls and clinical
populations with varied results (review: Dickinson and Elvevåg,
2009). One of the first links between the COMT enzyme and executive
functions (Egan et al., 2001) has been replicated in other studies
(Joober et al., 2002; Mattay et al., 2003; Rosa et al., 2004), yet other
groups have been unable to reproduce the results (Diaz-Asper et al.,
2008; Ho et al., 2005; Tsai et al., 2003). Other cognitive phenotypes
have also been studied including working memory, attentional
control, and episodic memories, with both positive (Blasi et al.,
2005; Goldberg et al., 2003) and negative results (Bilder et al., 2002;
Stefanis et al., 2004).
Many of the studies that explore the association between cognition
and the gene that encodes the COMT enzyme use neuropsychological
examinations, which are sensitive to differences among clinical
groups but do not have the ability to accurately determine differences
between genotypes (MacDonald et al., 2007). One strategy that could
prove useful in detecting cognitive differences between genotypes is
to employ cognitive paradigms that evaluate specific cognitive
functions or dysfunction instead of generalized deficits, which could
aid in the study of their biological correlates.
Numerous tests have demonstrated the ability to identify specific
deficits in cognitive functions dependent on the PFC. Among these
Table 1
Demographic and clinical characteristics.
Patients Relatives Controls ANOVA/ χ2
N 40 26 63
Age 37.2 (10.18) 49.27 (14.54) 36.36 (11.85) F = 11.64; gl = 2/126; p b 0.001
Sex 20F/20M 16F/10M 36F/27M χ2 = 1.41; p = NS
Level of Education
None 0% 4% 0%
Primary School 9.4% 18% 1.7%
Secondary Education 37.5% 18% 8.7%
Baccalaureate 19% 23% 43%
University 34.1% 46.6%
Years of Education 12.06 (3.27) 11.45 (4.5) 13.54 (2.45) F = 4.33; gl = 2/126; p = 0.01
COMT Genotype1 21VV/17VM/2MM 8VV/12VM/6MM 14VV/34VM/15MM
BPRS 9.5 (6.9)
PANSS-P 12 (3.3)
PANSS-N 19.2 (10.9)
PANSS-PG 34.2 (13.36)
CGI 3.21 (0.86)
GAF 64.64 (10.78)
Length of Illness 13.86 (8.57)
Diagnosis (DSM-IV):
Schizophrenia 27
Schizoaffective Disorder 6
Brief Psychotic Disorder 4
Schizotypal Personality Disorder 2
Delusional Disorder 1
Atypical Antipsychotics 95%
1 VV = Val/Val; VM = Val/Met; MM = Met/Met.
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specific prefrontal cognitive function, context processing. The cogni-
tive construct of context processing resembles the goal maintenance
construct and involves cognitive control functions. The deficits in
context processing appear to be specific to schizophrenia, detectable
in the early stages of the illness, and not significantly affected by
antipsychotic treatments (Barch et al., 2003). Various studies have
shown context processing deficits to be a stable cognitive feature of
schizophrenia (Cohen et al., 1999; Delawalla et al., 2008; Javitt et al.,
2000; Jones et al., 2010; MacDonald and Carter, 2003; MacDonald
et al., 2003; Stratta et al., 1998). Context processing also appears to be
linked to the functioning of the dorsolateral PFC (MacDonald and
Carter, 2003) and is thus likely linked to the dopaminergic system
(Cohen and Servan-Schreiber, 1992). A link has also been described
between context processing and the Val158Met COMT polymorphism
in healthy control subjects (Leung et al., 2007; MacDonald et al.,
2007). Individuals with the Val/Val genotype (low dopamine
availability in the PFC) show selective deficits in goal maintenance
in the DPX test.
In this study, we investigate the effect of the Val158/108Met COMT
polymorphism on context processing in patients on the schizophrenia
spectrum, their first-degree relatives, and healthy control subjects
using a cognitive neuroscience paradigm (the DPX). According to our
hypothesis, subjects with a Val/Val genotype should perform worse
on the context processing test due to the reduced dopamine
availability in the PFC.
2. Methods
2.1. Subjects
A total of 129 subjects were recruited for this study. Each subject
was genotyped for the Val158/108Met COMT polymorphism and
evaluated with the DPX. The clinical sample was recruited from
psychiatry examination rooms of a general hospital (University Clinic
of Navarra). Patient interviews and diagnoses were performed byresearch psychiatrists following the Structured Clinical Interview for
the DSM-IV (SCID). In the clinical sample group, 40 subjects were
found to be within the schizophrenia spectrum (schizophrenia, 27
patients; schizoaffective disorder, six patients; delusional disorder,
one patient; brief psychotic disorder, four patients; and schizotypal
personality disorder, two patients). A total of 26 subjects were
first-degree relatives of the patients who were free of psychotic
disorders, and 63 subjects were healthy controls. Both the relative and
control groups were evaluated using the non-pathological version of
the SCID. All patients were undergoing antipsychotic treatments at
the time of the evaluation. Participation in the study was voluntary,
and none of the subjects were paid for their participation. All subjects
were Caucasian and native Spanish speakers. After receiving a
description of the study, the subjects signed informed consent
forms. The study was approved by the Ethical Committee of Clinical
Investigation and followed the ethical principles of the international
standards required for performing human research.
The clinical and demographic data for the sample are shown in
Table 1. Clinical symptoms were evaluated using the following scales:
the Brief Psychiatric Rating Scale (BPRS), the Positive and Negative
Syndromes Scale (PANSS), Clinical Global Impression (CGI), and the
Global Assessment of Functioning Scale (GAF). All patients presented
with chronic forms of schizophrenia (average duration 13.86 ± 8.57
years) and were treated with antipsychotic medication (95% took
antipsychotic drugs).2.2. Genotyping
DNA was extracted from blood and saliva samples using a Qiamp
DNA Blood Mini Kit from Qiagen. Genotyping of the single nucleotide
polymorphism (SNP) Val158Met (rs4680) was performed via allelic
discrimination using real-time polymerase chain reaction (RT-PCR)
with a 7300 HT thermal cycler and TaqMan probes (TaqMan® SNP
Genotyping Assays, Applied Biosystems). Ten percent of the samples
were randomly selected to repeat the genotyping process for quality
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the Hardy-Weinberg equilibrium model.
2.3. Computer-based Cognitive Test
The cognitive function of context processing was evaluated with
the DPX (MacDonald et al., 2005), which consisted of a modified
version of the AX continuous performance task (AX-CPT) expectancy
test designed by Cohen et al. (Servan-Schreiber et al., 1996). The test
contains pairs of letters, and the subject is tasked with indicating the
letter X when it is preceded by the letter A (an AX pair). Any other
letter pair sequence should be ignored. The test is used to evaluate
context processing; the context of the first letter is needed to
determine whether the second letter fulfills the objective. Errors
involving BX pairs reflect a difficulty in representing and maintaining
the context; in these errors, X is selected as the objective, even though
it is not preceded by A. Errors involving AY pairs reflect proper context
representation (of the letter A) and are normally found in healthy
subjects, signifying a suitable capacity for context processing. Errors
involving all pairs of letters (AX, AY, BX, and BY) reflect the presence
of generalized deficits.
The DPX uses the same principles as the AX-CPT expectancy test
but with patterns of dots from the Braille alphabet rather than Latin
letters, resulting in an increase in difficulty in each of the conditions
and, therefore, a reduced test time. This test has been described in full
in other studies (Jones et al., 2010; MacDonald et al., 2005). The
duration of the DPX was 20 minutes. It was presented in four blocks,
each of which consisted of 40 pairs of letters. The different pairs were
presented in different percentages (70% AX, 12.5% AY, 12.5% BX, and
5% BY). The high proportion of AX presentation creates a tendency toFig. 1. DPX performance. A, Performance by group.select any letter that follows A as the objective. This manipulation of
the pair percentages produces a greater number of AY errors in
healthy subjects and of BX errors in subjects that have difficulty in
controlling the tendency to select X when it is not preceded by the
letter A.
2.4. Statistical analysis
The statistical analysis was performed with SPSS 15.0. Demo-
graphic differences between the groups were analyzed with analysis
of variance (ANOVA) and χ2 tests. To study context processing, the
analysis was focused on the AY and BX pairs, which specifically
measure this element of cognitive function. Error analysis was
performed with analysis of covariance (ANCOVA) using genotype
(Val/Val, Val/Met, and Met/Met) as the between-subject factor, letter
pairs (AY and BX) as the within-subject factor, and age and years of
schooling as covariables. Data from all groups were combined to
perform an analysis by genotype; separate analyses were performed
within each group (patients, relatives, and controls). Post-hoc tests
were performed, and Bonferroni corrections were used to correct for
multiple comparisons.
3. Results
The results of the DPX are shown in Fig. 1. A general ANCOVA of
errors showed a significant interaction between genotype, letter pairs,
and group (F = 3.07, P b 0.001). The proportion of errors by genotype
is shown in Tables 2 and 3. First, the effect of genotype on the entire
sample was examined. The ANCOVA showed a significant interaction
between genotype and pairs of letters (AY, BX) (F = 7.57, P b 0.001),B, Performance by Val158Met COMT genotype.
Table 2
Errors in context processing.
VV VM MM
Type of error M (SD) M (SD) M (SD)
AX 0.08 (0.004) 0.08 (0.003) 0.07 (0.005)
AY 0.18 (0.013) 0.14 (0.01) 0.2 (0.02)
BX 0.21 (0.014) 0.21 (0.012) 0.13 (0.02)
BY 0.07 (0.014) 0.05 (0.01) 0.06 (0.02)
Total 0.11 (0.004)1 0.1 (0.003)1 0.09 (0.005)1
Patients2 Relatives2 Controls2
VV VM MM VV VM MM VV VM MM
Type of error M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
AX 0.08 (0.006) 0.09 (0.007) 0.02 (0.01) 0.08 (0.01) 0.06 (0.01) 0.11 (0.01) 0.07 (0.01) 0.07 (0.004) 0.06 (0.006)
AY 0.23 (0.02) 0.18 (0.02) 0.08 (0.04) 0.13 (0.03) 0.1 (0.02) 0.24 (0.04) 0.14 (0.02) 0.14 (0.01) 0.2 (0.03)
BX 0.31 (0.02) 0.31 (0.02) 0.05 (0.04) 0.13 (0.03) 0.24 (0.03) 0.25 (0.04) 0.1 (0.02) 0.16 (0.01) 0.08 (0.02)
BY 0.13 (0.03) 0.1 (0.03) 0 (0) 0.02 (0.02) 0.02 (0.02) 0.2 (0.06) 0.01 (0.01) 0.04 (0.01) 0.01 (0.01)
M = Mean.
SD = Standard deviation.
VV = Val/Val genotype; VM = Val/Met genotype; MM = Met/Met genotype.
1 ANOVA (F = 2.36; p = 0.095).
2 ANCOVA: significant interaction between genotype, group, and pairs of letters (F = 3.07; p b 0.001).
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Val/Val and Val/Met subjects, while Met/Met subjects committed
more AY than BX errors. We did not find a primary effect of genotype
(F = 0.92, P = 0.4) or a primary effect of pairs of letters with respect
to the rate of errors (F = 0.08, P = 0.7). The three genotype groups
performed slower in response to the AY pairs than the BX pairs, with
the largest difference in reaction time found in the Met/Met group,
which demonstrated poor performance with AY pairs (thus reflecting
good context maintenance).
Then, error analyses were performed for each group separately. In
the patient group, the ANCOVA showed a primary effect of genotype
(F = 5.11; P b 0.05); patients with the Val/Val genotype committed
more errors than either the Val/Met or Met/Met patients (Val/
Val N Val/Met N Met/Met). No significant interaction between geno-
type and pairs of letters was observed (F = 2.78; p = 0.06), although
patients with the Val/Val and Val/Met genotypes committed more BX
than AY errors. In the relatives group, there was also an effect of
genotype (F = 6.24; P = 0.002) in which the Val/Val relatives
committed more errors than the Val/Met and Met/Met relatives. The
Val/Met and Met/Met relatives committed more BX errors than AY
errors, but this interaction was not significant between genotype and
letter pairs (F = 1.6; P = 0.2). In addition, we did not observe a
primary effect of pairs of letters (F = 1.6; P = 0.2), although relatives
committed more BX than AY errors. In the control group, the ANCOVA
showed a significant interaction between genotype and pairs of letters
(F = 5.4; P = 0.004). In this group, Val/Val subjects and Met/Met
subjects committed more errors for AY than for BX pairs. A primaryTable 3
Results of the DPX: BX-AY difference.
M (SD) ES
VV vs. VM 0.07 (0.31) 0.07 (0.23) 0.01
VM vs. MM 0.07 (0.23) −0.07 (0.22) 0.61
VV vs. MM 0.07 (0.31) −0.07 (0.22) 0.49
VV Patients vs. MM Patientsa 0.16 (0.38) 0.11 (0.27) 0.16
VV Relatives vs. MM Relativesa −0.001 (0.1) 0.88 (0.08) 10.58
VV Controls vs. MM Controlsa −0.04 (0.21) −0.01 (0.21) 0.14
M = Mean.
SD = Standard deviation.
ES = Effect size.
VV = Val/Val subjects; VM = Val/Met subjects; MM = Met/Met subjects.
a MM = both VM and MM groups.effect of letter pairs was also observed (F = 8.61; P = 0.003); healthy
control subjects committed more AY than BX errors.
4. Discussion
In this study, we investigated the impact of the Val158Met COMT
genotype on context processing in patients on the schizophrenia
spectrum and in their relatives using the DPX. Our results demon-
strated a relationship between the Val158Met COMT polymorphism
and context processing.
Links between cognitive activity and the COMT genotype have
been inconsistent in the literature. In samples of healthy controls,
some studies have found positive associations (Blasi et al., 2005;
Bruder et al., 2005; Papaleo et al., 2008), while others have found no
association (Stefanis et al., 2004). In patients with schizophrenia, both
positive (Egan et al., 2001; Goldberg et al., 2003; Wirgenes et al.,
2010) and negative (Bilder et al., 2002; Liao et al., 2009; Mata et al.,
2008) associations between the COMT genotype and cognition have
been published. Patients with schizophrenia seem to show a similar
pattern to healthy patients; those with a homozygous Met genotype
appear to show better cognitive performance than those with a
homozygous Val genotype. A recent meta-analysis on the effects of
the Val158Met COMT polymorphism on cognition (Barnett et al.,
2008) concluded that there is weak evidence of an association
between this polymorphism and cognitive function. There are
multiple explanations for why this lack of association has been
claimed. First and most importantly, researchers regularly employ
neuropsychological batteries to study cognitive function; these
batteries study neurophysiological dominions, which tend to be
compound constructions and, therefore, difficult to associate with any
one specific genetic variant. Additionally, different versions of the
batteries are used in different studies, making it difficult to interpret
results across studies.
The development of cognitive neuroscience paradigms that viably
evaluate the function of a specific neural system is a promising
approach to evaluate the association between genes and cognition
(Green et al., 2008). Based on this principle, we used the DPX in our
study. Our results support the finding of a link between the
Val158Met COMT polymorphism and context processing in healthy
controls and patients with schizophrenia.
According to the theory of context processing, evaluated using
variants of the AX-CPT expectancy test, subjects with a deficit in
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BX letter pair, while those with intact context processing would
commit more errors involving the AY pair (MacDonald, 2008). The
pattern of errors in this task is more indicative of deficits in context
processing than the total number of errors. As described in the results
and shown in Fig. 1, both patients and their relatives performed better
with the AY pairs than with the BX pairs, implying poor context
processing, while the healthy controls showed better performance
with the BX pairs than with the AY pairs, reflecting better context
processing. The subjects that developed a tendency to respond (i.e.,
recognize a response as the objective) when they recognized the
letter A committed more errors with the AY pairs than subjects with
deficits in context processingwhowere incapable of using the context
provided by the first letter of the pair. The most common pattern
shown in studies on schizophrenia using variants of the AX-CPT
expectancy test is an interaction of groups and type of letter pair,
caused by a disproportionately worse performance with BX pairs than
with AY pairs by patients (Barch et al., 2001, 2003; Javitt et al., 2000).
There is evidence to suggest that deficits in context processing are
endophenotypic markers of the risks of schizophrenia because
healthy relatives of patients with schizophrenia also showed deficits
in context processing (Delawalla et al., 2008; MacDonald et al., 2003).
Studies with the DPX have also shown that healthy relatives of
patients with schizophrenia exhibit deficits in context processing
(MacDonald et al., 2005). Our study showed that relatives, as well as
patients, exhibit a primary effect of genotype; Val/Val and Val/Met
subjects demonstrated a poorer performance in the BX condition than
in the AY condition, reflecting a deficit in context processing and
supporting the idea that deficits in context processing are, conse-
quently, a valid endophenotype of schizophrenia.
This study has a number of limitations. The groups consisted of
subjects with different age ranges; the relatives were older than the
patients and the controls because themajority of first-degree relatives
were the parents of the patients. Therefore, an analysis was performed
including age as a covariable, and the results were similar.
Nevertheless, we propose that age is an important factor that should
be taken into account. Medication could be a source of potential bias
as well. At the time that the sample of clinical patients was obtained,
all were undergoing antipsychotic treatment. Although it is possible
that the medication could contribute to poor cognitive performance,
numerous studies have shown that cognitive deficits in patients with
schizophrenia are present even though the antipsychotic treatment
controls for positive symptoms. A study by Barch et al. (2003),
comparing medicated and unmedicated patients with respect to their
first schizophrenic episode showed that deficits in context processing
are present even before treatment. The size of the sample was another
limitation of our study. Individual genes could have relatively small
effects on the cognitive phenotype, and thus larger samples should be
studied to produce more viable conclusions and to reproduce our
results. The Val158Met COMT polymorphism is also associated with
impulsivity, which could explain the larger number of errors in
patients with the Val/Val genotype.
The results of this study suggest that the use of cognitive neuroscience
measures, linked specifically to the neural circuitry and with molecular
characteristics related to the products of specific genes, may be a
promising approach to establish informative links between the genotype
and cognitive phenotype in the field of psychiatric genetics.
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